Back in the trenches after ASH 2016

| John Auerbacher

BACK IN THE TRENCHES AFTER 2016 ASH Less than a day after returning from 2016 ASH, our IMF Westchester [NY] Support Group met for our monthly meeting. The format spontaneously changed into a two-hour discussion, in place of our customary round table where each person has an opportunity to discuss their current status and to […]

MRD measurement and BSRI are bringing us closer to cure

| Jim Omel

Patients understand that improved treatment for myeloma can result in unprecedented depth of response, and myeloma treatment has changed dramatically in the last few years. Prior to 1997 when I was diagnosed, complete response (CR) was defined as a 75% reduction in M-protein. Stringent CR (sCR) did not exist because this deep level of control […]

Coming full circle

| Linda Huguelet

I’m honored to have been invited by the International Myeloma Foundation (IMF) to attend the American Society of Hematology (ASH) Annual Meeting for the fourth year.  Since attending my first ASH, I’ve been continually amazed and encouraged by the vast amount of myeloma research that is being done. It’s truly inspiring to see research in […]